Skip to main content
Membership NewsMembership News Archive

MHRA MedTech Regulatory Reform Webinar recording

The MHRA have released the recording of the MedTech Regulatory Reform Webinar, which took place on 5 March 2024. The webinar covered the intentions regarding scope, classification of general medical devices and IVDs, essential requirements and information to be provided with medical devices. You can access it here or below. https://www.youtube.com/watch?v=KjwOfdj14jo
Ben Kemp
April 2, 2024
Membership NewsMembership News Archive

Digital Working Party survey expected soon

Members should brace themselves for a survey linked to the relaunch of the Digital Working Party, which will be distributed imminently. We would greatly appreciate members' feedback as digital is such a crucial, multi-faceted topic for health, but which has hitherto struggled to maintain an established focus in previous Digital Working Parties. We would like to reach a healthy equilibrium…
Ben Kemp
April 2, 2024
Membership NewsMembership News Archive

Private Sector Opportunity in Uruguay

We have received another request from the British Embassy in Uruguay, following their recent request for rapid dengue fever tests. A well-established Uruguayan company is looking for UK suppliers of: Human rapid tests for: RPR test for the Serodiagnosis of Syphilis TPHA Treponema pallidum hemagglutination ABO 0 system blood groups and RH factor Urinalysis strips Molecular Diagnosis. Sample to result RT PCR system.…
Ben Kemp
April 2, 2024
Membership NewsMembership News Archive

BIVDA Board Member Profile: Jane Meaney

Jane Meaney, AMLo Biosciences, was elected to the BIVDA Board last month. In a new series for the BIVDA newsletter, we will be profiling each of our board members to ensure greater visibility for members. Learn more about Jane below: 'I am Chief Marketing Office at AMLo Biosciences, a spin-out from Newcastle University. AMLo is a rare female founded tech…
Ben Kemp
April 2, 2024
Membership NewsMembership News Archive

BIVDA meet with MHRA’s senior leadership

On Thursday 28th March, BIVDA's Helen Dent, Mike Messenger, Stuart Angell and Paul Fisher met with Medicines and Healthcare products Regulatory Agency CEO Dame June Raine, co-chair Amanda Calvert, and members of their executive leadership. The meeting is part of a series of bilateral meetings between the MHRA and BIVDA to provide a high-level update on the top-level activities of the two…
Ben Kemp
April 2, 2024
Membership NewsMembership News Archive

The BIVDA Board and its Role

As announced at the AGM, the board has welcomed three new members for following three years. Kam Pooni, Glyconics, was successfully re-elected to the board, while Mark Jackman, DiaSorin, and Jane Meaney, AMLoBiosciences, have joined for the first time. The board consists of 15 elected representatives from BIVDA member companies alongside our President Angela Douglas and Chief Executive Helen Dent.…
Ben Kemp
March 27, 2024
Membership NewsMembership News Archive

BIVDA Meeting Rooms

Over the Easter period, our office will be undergoing some improvements. Regretfully, during this time we will not be able to accept any member bookings for our meeting rooms. The project will allow us combine the Madden and Fishwick Rooms. A concertina door will replace the existing wall between the Madden and Fishwick Rooms, to increase theatre style seating from…
Ben Kemp
March 27, 2024
Membership NewsMembership News Archive

BIVDA AGM: Summary

BIVDA held our AGM at One Great George Street last Wednesday. The packed audience heard the release of our new strategy, expert presentations, and the announcement of BIVDA’s new board members and Chief Executive. The strength of the new BIVDA team was displayed for all to see at the front of the auditorium: New Chief Executive Helen Dent, Head of…
Ben Kemp
March 27, 2024
ConsultationsConsultations ArchiveMembership NewsMembership News Archive

NICE Consultations and Guidelines: Technology Appraisal, Endemetriosis, Ovarian Cancer, Meningitis (bacterial) and meningococcal disease

NICE consultation on Methods and processes for including NICE technology appraisal recommendations in guidelines The consultation period for Methods and processes for including NICE technology appraisal recommendations in guidelines closes at 17:00 on Friday 05 April 2024. Meningitis (bacterial) and meningococcal disease  The final Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management guideline has now been published on the…
Ben Kemp
March 26, 2024
Membership NewsMembership News Archive

BIVDA is delighted to confirm the appointment of Helen Dent as Chief Executive

The British In Vitro Diagnostic Association (BIVDA) is delighted to confirm the appointment of Helen Dent as Chief Executive, following a successful period as Interim Chief Executive. Helen will lead BIVDA in championing the medical diagnostics industry to politicians, policymakers, media and relevant stakeholders and in supporting members to improve patient outcomes. Helen’s first act as Chief Executive was to…
Ben Kemp
March 26, 2024